Literature DB >> 33710762

Deepen into sleep and wake patterns across Alzheimer's disease phenotypes.

Neus Falgàs1,2,3, Christine M Walsh1, Thomas C Neylan1,4, Lea T Grinberg1,2,5,6.   

Abstract

Although, the clinical variants of Alzheimer's disease (AD) show distinct patterns of cognitive and behavioral decline, disease progression, and neuropathological features, it is unclear if this clinical heterogeneity extends to sleep-wake patterns. Sleep and wake disturbances are frequent in typical AD, often preceding memory loss and negatively impacting the quality of life of patients and caregivers alike. Still, sleep and wake disorders are often misdiagnosed and undertreated in typical AD. Better characterization of sleep-wake features in AD clinical variants is an unmet gap of high importance because these differing patterns may require tailored treatment strategies. Moreover, as wake-promoting neurons are located in subcortical nuclei and degenerate early in typical AD, contrasting the profiles of sleep-wake patterns in typical and atypical AD aids diagnosis and brings a unique opportunity to uncover the mechanisms underlying AD clinical variants at the subcortical level and mechanisms for selective neuronal vulnerability.
© 2021 the Alzheimer's Association.

Entities:  

Keywords:  Alzheimer's disease; Brainstem; neuromodulatory subcortical systems; selective vulnerability; sleep

Mesh:

Year:  2021        PMID: 33710762      PMCID: PMC8364869          DOI: 10.1002/alz.12304

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   16.655


  21 in total

1.  Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study.

Authors:  Melissa E Murray; Neill R Graff-Radford; Owen A Ross; Ronald C Petersen; Ranjan Duara; Dennis W Dickson
Journal:  Lancet Neurol       Date:  2011-07-27       Impact factor: 44.182

2.  Non-amnestic mild cognitive impairment and sleep complaints: a bidirectional relationship?

Authors:  Luca Rozzini; Marta Zaffira Conti; Maddalena Riva; Anna Ceraso; Salvatore Caratozzolo; Marina Zanetti; Alessandro Padovani
Journal:  Aging Clin Exp Res       Date:  2017-08-28       Impact factor: 3.636

3.  Profound degeneration of wake-promoting neurons in Alzheimer's disease.

Authors:  Jun Oh; Rana A Eser; Alexander J Ehrenberg; Dulce Morales; Cathrine Petersen; Jessica Kudlacek; Sara R Dunlop; Panos Theofilas; Elisa D P F Resende; Celica Cosme; Eduardo J L Alho; Salvatore Spina; Christine M Walsh; Bruce L Miller; William W Seeley; Jackson C Bittencourt; Thomas C Neylan; Helmut Heinsen; Lea T Grinberg
Journal:  Alzheimers Dement       Date:  2019-08-12       Impact factor: 21.566

4.  Neuropsychiatric Profile in Early Versus Late Onset Alzheimer's Disease.

Authors:  Maria do Céu Ferreira; Maria João Abreu; Célia Machado; Beatriz Santos; Álvaro Machado; Ana Sofia Costa
Journal:  Am J Alzheimers Dis Other Demen       Date:  2017-12-06       Impact factor: 2.035

Review 5.  Sleep and Alzheimer's disease: A pivotal role for the suprachiasmatic nucleus.

Authors:  Jan Van Erum; Debby Van Dam; Peter Paul De Deyn
Journal:  Sleep Med Rev       Date:  2017-07-28       Impact factor: 11.609

6.  Locus coeruleus volume and cell population changes during Alzheimer's disease progression: A stereological study in human postmortem brains with potential implication for early-stage biomarker discovery.

Authors:  Panos Theofilas; Alexander J Ehrenberg; Sara Dunlop; Ana T Di Lorenzo Alho; Austin Nguy; Renata Elaine Paraizo Leite; Roberta Diehl Rodriguez; Maria B Mejia; Claudia K Suemoto; Renata Eloah De Lucena Ferretti-Rebustini; Livia Polichiso; Camila F Nascimento; William W Seeley; Ricardo Nitrini; Carlos Augusto Pasqualucci; Wilson Jacob Filho; Udo Rueb; John Neuhaus; Helmut Heinsen; Lea T Grinberg
Journal:  Alzheimers Dement       Date:  2016-08-08       Impact factor: 21.566

7.  Neuropathologic Correlates of Psychiatric Symptoms in Alzheimer's Disease.

Authors:  Alexander J Ehrenberg; Claudia K Suemoto; Elisa de Paula França Resende; Cathrine Petersen; Renata Elaine Paraizo Leite; Roberta Diehl Rodriguez; Renata Eloah de Lucena Ferretti-Rebustini; Michelle You; Jun Oh; Ricardo Nitrini; Carlos Augusto Pasqualucci; Wilson Jacob-Filho; Joel H Kramer; Jennifer R Gatchel; Lea T Grinberg
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

Review 8.  Histamine: neural circuits and new medications.

Authors:  Thomas E Scammell; Alexander C Jackson; Nicholas P Franks; William Wisden; Yves Dauvilliers
Journal:  Sleep       Date:  2019-01-01       Impact factor: 5.849

9.  Association between sleep disturbance in Alzheimer's disease patients and burden on and health status of their caregivers.

Authors:  Shoki Okuda; Jumpei Tetsuka; Kenichi Takahashi; Yasuo Toda; Takekazu Kubo; Shigeru Tokita
Journal:  J Neurol       Date:  2019-04-09       Impact factor: 4.849

Review 10.  Sleep, circadian rhythms, and the pathogenesis of Alzheimer disease.

Authors:  Erik S Musiek; David D Xiong; David M Holtzman
Journal:  Exp Mol Med       Date:  2015-03-13       Impact factor: 8.718

View more
  3 in total

1.  Subcortical Neuronal Correlates of Sleep in Neurodegenerative Diseases.

Authors:  Jun Y Oh; Christine M Walsh; Kamalini Ranasinghe; Mihovil Mladinov; Felipe L Pereira; Cathrine Petersen; Neus Falgàs; Leslie Yack; Tia Lamore; Rakin Nasar; Caroline Lew; Song Li; Thomas Metzler; Quentin Coppola; Natalie Pandher; Michael Le; Hilary W Heuer; Helmut Heinsen; Salvatore Spina; William W Seeley; Joel Kramer; Gil D Rabinovici; Adam L Boxer; Bruce L Miller; Keith Vossel; Thomas C Neylan; Lea T Grinberg
Journal:  JAMA Neurol       Date:  2022-05-01       Impact factor: 29.907

2.  The severity of neuropsychiatric symptoms is higher in early-onset than late-onset Alzheimer's disease.

Authors:  Neus Falgàs; Isabel E Allen; Salvatore Spina; Harli Grant; Stefanie D Piña Escudero; Jennifer Merrilees; Rosalie Gearhart; Howard J Rosen; Joel H Kramer; William W Seeley; Thomas C Neylan; Bruce L Miller; Gil D Rabinovici; Lea T Grinberg; Christine M Walsh
Journal:  Eur J Neurol       Date:  2021-12-20       Impact factor: 6.288

Review 3.  New approaches for the quantification and targeting of noradrenergic dysfunction in Alzheimer's disease.

Authors:  Michael David; Paresh A Malhotra
Journal:  Ann Clin Transl Neurol       Date:  2022-03-15       Impact factor: 4.511

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.